Skip to main content

Biomatters' Geneious Biologics SAAS

Biomatters has released a new version of Geneious Biologics, an enterprise software-as-a-service solution for commercial antibody screening and discovery. The new release features a capability that will allow developers of biological drugs to analyze millions of raw antibody sequences in minutes, accelerating the identification of therapeutic antibody candidates. The software enables users to preview, annotate, and compare NGS sequnces with no manual intervention, the company noted.

The Scan

And For Adolescents

The US Food and Drug Administration has authorized the Pfizer-BioNTech SARS-CoV-2 vaccine for children between the ages of 12 and 15 years old.

Also of Concern to WHO

The Wall Street Journal reports that the World Health Organization has classified the SARS-CoV-2 variant B.1.617 as a "variant of concern."

Test for Them All

The New York Times reports on the development of combined tests for SARS-CoV-2 and other viruses like influenza.

PNAS Papers on Oral Microbiome Evolution, Snake Toxins, Transcription Factor Binding

In PNAS this week: evolution of oral microbiomes among hominids, comparative genomic analysis of snake toxins, and more.